Methicillin-resistant staphylococcus aureus nosocomial infection has a distinct epidemiological position and acts as a marker for overall hospital-acquired infection trendsArticle Published on 2022-10-112022-11-15 Journal: Scientific Reports [Category] 바이오마커, [키워드] Analysis Biomarker Care Control COVID-19 pandemic dataset disease Diseases drug-resistant Efficacy epidemiological epidemiologist HAI healthcare hospital hospitalized patients Infection lack Lower marker microbe MRSA Nosocomial infection Nosocomial infections outbreak pathogen Patient prevented reduced replaced Staphylococcus aureus Stress threshold unique USA [DOI] 10.1038/s41598-022-21300-6 PMC 바로가기
Inflammatory and thrombotic parameters associated with the COVID-19 course in Poland (SARSTer study)Article Published on 2022-09-012022-11-15 Journal: Advances in medical sciences [Category] 바이오마커, [키워드] analyzed Anticoagulants C-reactive protein clinical Clinical improvement Coagulation Concentration Course COVID-19 CRP D-dimer database Dexamethasone diagnosed with COVID-19 epidemiologist examined ferritin group IL-6 Inflammatory marker interleukin-6 Laboratory parameters Logistic regression Lymphocyte count material Mild multivariate National neutrophil neutrophil count not differ outcome parameter parameters Patient patients Platelet Poland predictor procalcitonin Remdesivir selected Significant significant difference significantly significantly higher study population supported the disease thrombotic Tocilizumab Treatment WBCs White blood cell [DOI] 10.1016/j.advms.2022.07.003 PMC 바로가기
WEENet: An Intelligent System for Diagnosing COVID-19 and Lung Cancer in IoMT EnvironmentsOncology Published on 2022-02-022022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] assist cancer categorization Care caused Chest Computed tomography coronavirus disease COVID-19 COVID-19 diagnosis COVID-19 pandemic dataset deep learning detect develop diagnose early diagnosis early stage effective eight Environment epidemiologist evaluated evaluation metrics Features Health healthcare infected patient Internet internet of medical things machine learning management mechanism Medical imaging outbreak outcome pandemic patients Performance metrics System Treatment X-ray imaging [DOI] 10.3389/fonc.2021.811355 PMC 바로가기 [Article Type] Oncology
Unequal impact and spatial aggregation distort COVID-19 growth ratesArticles Published on 2022-01-102022-10-28 Journal: Philosophical transactions. Series A, Mathematical [Category] Coronavirus, MERS, SARS, [키워드] aggregation aggregation bias Analysis approach COVID-19 COVID-19 pandemic death Epidemic epidemiologist growth growth rate Infection infections Infectious disease Lower mechanism public health public policy Reed–Hughes mechanism Region the disease [DOI] 10.1098/rsta.2021.0122 PMC 바로가기 [Article Type] Articles
Field epidemiology training programs contribute to COVID-19 preparedness and response globallyResearch Published on 2022-01-102022-10-28 Journal: BMC Public Health [Category] Coronavirus, SARS, [키워드] activities activity Analysis Community conducted contribute contributed contributing to country COVID-19 Critical cross-sectional survey description effort eight ENhance epidemiological epidemiologist Epidemiology FETP field Field epidemiology global health global health security Guidance help indicated International Health Regulations Pandemic response pillar plan provide public health public health emergency public health threat qualitative data Quantitative rapid response regions response Result risk Seven supplementary material Surveillance Threats WHO WHO’ World Health Organization’ [DOI] 10.1186/s12889-021-12422-z PMC 바로가기 [Article Type] Research
COVID-19 data are messy: analytic methods for rigorous impact analyses with imperfect dataCommentary Published on 2022-01-062022-11-01 Journal: Globalization and Health [Category] COVID-19, SARS, [키워드] addressed Analysis approach comparability Completeness COVID-19 COVID-19 pandemic COVID-19 research Effectiveness effort epidemiologist explicit Government help identify Impact analysis Interrupted time-series analysis Intervention longitudinal study Non-pharmaceutical interventions observational studies outcome problem recommendation Research researcher Result sensitivity analysis Study design Surveillance biases surveillance data threat Validity variable variables [DOI] 10.1186/s12992-021-00795-0 PMC 바로가기 [Article Type] Commentary
Living in a pandemic: changes in mobility routines, social activity and adherence to COVID-19 protective measuresArticle Published on 2021-12-272022-10-29 Journal: Scientific Reports [Category] COVID-19, SARS, [키워드] addressed changes in Computational science Contact COVID-19 COVID-19 pandemic diffusion epidemiologist Evolution increase individual Intervention less Local measure NPI NPIs pandemic Protective public health reducing risk severity [DOI] 10.1038/s41598-021-04139-1 PMC 바로가기 [Article Type] Article
Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective StudyArticle Published on 2021-12-252022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] administration analyzed Antiviral change changes in Clinical outcome Concentration confidence COVID-19 COVID-19 pandemic death Department died effective epidemiologist IL-6 increase in individual Infectious disease Inflammatory marker inflammatory markers interleukin-6 lactate dehydrogenase LDH outcome outcomes Patient patients treated Poland predict Predictive Prognostic factor ROC Curve SARS-CoV-2 SARS-CoV-2-positive patient selected serum Serum level severe cases significantly higher Survivors Tocilizumab treated Treatment [DOI] 10.3390/jcm11010107 PMC 바로가기 [Article Type] Article
Clinical profile and short-term outcomes of RT-PCR- positive patients with COVID-19: a cross-sectional study in a tertiary care hospital in Dhaka, BangladeshObservational Study Published on 2021-12-152022-10-05 Journal: BMJ Open [Category] SARS, 임상, [키워드] age Antibiotics anticoagulant therapy Asia Asthma attribute average Care case sery Characteristics clinical Clinical features clinician Comorbidity Complication complications cough country COVID-19 COVID-19 mitigation COVID-19 pandemic COVID-19 symptom cross-sectional diabetes died discharge Dyspnoea effort enrolled epidemiological epidemiologist Epidemiology Evidence female patient Fever Gender group Health healthcare hospital hospitalisation hypertension Infectious diseases Ischaemic heart disease majority male medical record outcome outcomes over pathology Patient patients with COVID-19 positive patient proportion public health reported Research reverse transcription-PCR RT-PCR significantly higher sore throat Symptom the patient Therapeutics treatment history while [DOI] 10.1136/bmjopen-2021-055126 PMC 바로가기 [Article Type] Observational Study
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd ImmunityReview Published on 2021-10-292022-10-31 Journal: Cells [Category] COVID-19, MERS, SARS, [키워드] acute respiratory distress acute respiratory syndrome addition aetiology affected alveolar epithelial cells antigenicity approval ARDS authority caused Cell-mediated immune responses characterized China clinical trial clinical trials coronavirus disease coronavirus disease 19 Coronaviruses COVID-19 COVID-19 vaccine death deaths develop development Disadvantages disease Effective vaccines Efficiency EMA epidemiologist European family Coronaviridae genus Betacoronavirus glycoprotein H1N1 Herd herd immunity humoral immune response Immunity immunocompromised individuals immunogenic immunogenic potential Infection Infectious disease Influenza insight janssen Lungs majority Medicine MERS Middle East morbidity and mortality Nidovirales non-structural proteins organ Orthocoronavirinae other tissue outbreak pandemic Prognosis prophylactic measure PROTECT psychosomatic reduce reported researchers Safe SARS-CoV SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 pandemic severe patients structural protein syndrome therapeutic agents vaccination Vaccine Vaccine development Vaccines Viral diseases VoC Wuhan [DOI] 10.3390/cells10112949 PMC 바로가기 [Article Type] Review